Sanofi (SNYNF)

Market Cap	111.36B -17.3%
Revenue (ttm)	54.85B +5.5%
Net Income	9.17B +40.5%
EPS	7.52 +44.2%
Shares Out	n/a
PE Ratio	12.14
Forward PE	9.33
Dividend	n/a
Ex-Dividend Date	n/a

Volume	163
Average Volume	68,430
Open	92.98
Previous Close	97.11
Day's Range	92.98 - 92.98
52-Week Range	90.05 - 122.03
Beta	0.37
RSI	45.35
Earnings Date	Jan 29, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepati...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1994
• Employees: 82,878
• Stock Exchange: OTCMKTS
• Ticker Symbol: SNYNF

Financial Performance

In 2025, Sanofi's revenue was 46.72 billion, an increase of 5.49% compared to the previous year's 44.29 billion. Earnings were 7.81 billion, an increase of 40.52%.

Financial numbers in EUR